Harvard Medical School publication to improve health and quality of life for men with prostate disease  

BOSTON, Feb. 5 /PRNewswire-USNewswire/ -- Harvard Health Publications, the publishing division of Harvard Medical School, has released the premier issue of a quarterly publication entitled "Harvard Medical School Perspectives on Prostate Disease."  

The publication is created to help men understand the options available to them, so they can make intelligent treatment decisions and maintain optimal quality health and quality of life.

According to Dr. Marc Garnick, Editor in Chief, "Few men think about their prostate gland until they develop some kind of problem. Then it may be all they can think about. If you have recently been diagnosed with prostate disease, you know how difficult it can be to find the in-depth and reliable information that will help you make informed choices....

'Perspectives on Prostate Disease' was created to address these issues. Our mission in launching this quarterly newsletter is to provide multiple perspectives about how best to treat the most common prostate diseases -- prostate cancer, benign prostatic hyperplasia, and prostatitis -- as well as related conditions such as erectile dysfunction and low testosterone levels."

To ensure the most accurate and objective information possible, the editorial comment is devoid of any commercial bias. "Perspectives" is supported in part by a grant from a charitable nonprofit family foundation.

The publication's editorial board consists of eminent and respected Harvard and European physicians, all of whom have expertise in the disorders covered by "Perspectives."

The articles in the premier issue include:

    -- Treat or wait?

    -- When to consider active surveillance

    -- A patient's story: Why one man opted for lifestyle changes instead of treatment

    -- A patient's story: Why one man chose robotic-assisted laparoscopic prostatectomy

 -- Your benign prostatic hyperplasia medication: When to consider a change

    -- Harvard experts discuss benign prostatic hyperplasia drug treatments

    -- Search PubMed in five easy steps.

    The next issue includes:

    -- Complementary therapies for prostate disease: What works, what doesn't

    -- What's new in treating erectile dysfunction

    -- How to handle a relapse: Your options if a PSA tests reveals your cancer has returned.

    The Charter Subscription Rate for one year (4 quarterly issues) is $99.

Harvard Medical School Perspectives on Prostate Disease
PO Box 9308
Big Sandy, TX 75755-9308